Pharma Journalist -

Mallinckrodt plc affirmed enrolling first patient in the company's Phase 4, multi center, randomized, double-blind, placebo-controlled pilot study to facilitate evaluation of the…
Read More...

U.S  Food and Drug Administration conceded to Multi  Radiance Medical's MR4 Laser technology for neck and shoulder pain relief under the Product Classification NHN. MR4 Laser technology…
Read More...

Takeda Pharmaceutical company Limited asserted that the U.S Food and Drug Administration has extended Fast Track designation to TAK-426 i.e Takeda's Zika virus vaccine candidate. …
Read More...

European Organisation for Research and Treatment of Cancer (EORTC) and Foundation Medicine collaborate to ascertain eligibility of patients for oncology clinical Trials of  Foundation…
Read More...

In a bid to commercialize NERLYNX, Puma Biotechnology and Medison Pharma have forayed into an exclusive licensing agreement in Israel as it is currently not approved for…
Read More...

U.S Patent and Trademark Office permits a patent titled  “Method for Inducing an Immune Response and Formulations Thereof” for CEL-SCI Corporation's LEAPS Vaccine Platform technology.…
Read More...

Agilent Technologies ventured into a partnership with Science Exchange to met out Agilent-enabled services to the research community worldwide. Carolina Livi, Ph.D., academic segment…
Read More...

International contract research organization (CRO), Synteract paved way for a new Chief Commercial Officer on board, Jack Shannon. Jack Shannon joins Synteract from Chiltern where he…
Read More...

Sanofi and Ablynx engaged in the discovery and development of Nanobodies forayed into an agreement under which Sanofi will extend acquisition of all of the outstanding ordinary shares,…
Read More...

U.S. Food and Drug Administration (FDA) has approved BioCardia's Investigational Device Exemption for the CardiAMP Chronic Myocardial Ischemia (CMI) Trial to treat patients with…
Read More...